Bin Zheng

18PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples epidemiologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 01, 2026
Low Skeletal Muscle Index Predicts Neoadjuvant Immunochemotherapy Tolerance and Survival in Oesophageal Squamous Cell Carcinoma.

|Aug 04, 2026
Predicting Anastomotic Leak After Neoadjuvant Chemoimmunotherapy and Esophagectomy: A Dynamic Inflammatory and Nutritional Biomarker Model.

|May 27, 2026
Angiotensin inhibitors during neoadjuvant chemotherapy improve esophageal squamous cell carcinoma outcomes.

|Apr 10, 2026
Casein kinase 2-mediated phosphorylation of the splicing factor SF3B3 plays a key role in esophageal squamous cell carcinoma progression.

Du-Chuang Wang, Jia-Yuan Li, Xiao-Bing Wang

|Oct 15, 2025
Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3).

Xipeng Wang, Chengqiang Li, Yuqin Cao

|Sep 13, 2025
Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy.

Yizhou Huang, Maohui Chen, Yuanpu Wei

Pageof 3

Frequent Collaborators

7 joint publications

Chun Chen

3 joint publications

Jianting Du

3 joint publications

Yizhou Huang

3 joint publications

Maohui Chen